1. First in Human Phase I Trial of Dual Vector (HSV1-TK, Flt3L) Immunotherapy For The Treatment of Newly Diagnosed High-Grade Glioma: Initial Results. (1st September 2019) Authors: Orringer, Daniel A; Sagher, Oren; Heth, Jason; Hervey-Jumper, Shawn L; Mammoser, Aaron; Junck, Larry; Leung, Denise; Umemura, Yoshie; Lawrence, Theodore; Kim, Michelle; Wahl, Dan; McKeever, Paul; Camelo-Piragua, Sandra; Lieberman, Andrew; Venneti, Sriram; Verbal, Kait; Sagher, Karen; Dunn, Patric... Journal: Neurosurgery Issue: Volume 66(2010)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. First in Human Phase I Trial of Dual Vector (HSV1‐TK, Flt3L) Immunotherapy For The Treatment of Newly Diagnosed High‐Grade Glioma: Initial Results. (September 2019) Authors: Orringer, Daniel A; Sagher, Oren; Heth, Jason; Hervey‐Jumper, Shawn L; Mammoser, Aaron; Junck, Larry; Leung, Denise; Umemura, Yoshie; Lawrence, Theodore; Kim, Michelle; Wahl, Dan; McKeever, Paul; Camelo‐Piragua, Sandra; Lieberman, Andrew; Venneti, Sriram; Verbal, Kait; Sagher, Karen; Dunn, Patric... Journal: Neurosurgery Issue: Volume 66(2019)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗